Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
12.660
Open
12.130
VWAP
12.29
Vol
143.57K
Mkt Cap
158.11M
Low
11.990
Amount
1.76M
EV/EBITDA(TTM)
8.05
Total Shares
12.70M
EV
130.23M
EV/OCF(TTM)
9.70
P/S(TTM)
0.71
LifeVantage Corporation is engaged in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. The Company's dietary supplements include its flagship Protandim family of products, LifeVantage Omega+, ProBio, IC Bright, and Daily Wellness dietary supplements. The Protandim product line includes Protandim NRF1 Synergizer, Protandim Nrf2 Synergizer, and Protandim NAD Synergizer. TrueScience is its line of skin, hair, bath and body, and targeted relief products. The Company also markets and sells Petandim, its companion pet supplement formulated to combat oxidative stress in dogs; Axio, its nootropic energy drink mixes, and PhysIQ, its smartweight management system, which includes PhysIQ Fat Burn and PhysIQ Prebiotic, all formulated to aid in weight management.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
63.60M
+29.98%
0.240
+71.43%
57.99M
+22.81%
0.210
+40%
74.01M
+9.22%
0.410
+86.36%
Estimates Revision
The market is revising No Change the revenue expectations for LifeVantage Corporation (LFVN) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -34.14%.
Revenue Estimates for FY2025
No Change
0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change
0.00%
In Past 3 Month
Stock Price
Go Down
-34.14%
In Past 3 Month
2 Analyst Rating
138.85% Upside
Wall Street analysts forecast LFVN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for LFVN is 30.00 USD with a low forecast of 30.00 USD and a high forecast of 30.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
0 Hold
0 Sell
Moderate Buy
138.85% Upside
Current: 12.560
Low
30.00
Averages
30.00
High
30.00
138.85% Upside
Current: 12.560
Low
30.00
Averages
30.00
High
30.00
Craig-Hallum
Alex Fuhrman
Strong Buy
Initiates
$35
2025-01-14
Reason
Craig-Hallum
Alex Fuhrman
Price Target
$35
2025-01-14
Initiates
Strong Buy
Reason
Craig-Hallum analyst Alex Fuhrman initiated coverage of LifeVantage with a Buy rating and $35 price target.
Lake Street
Brooks O'Neil
Strong Buy
Initiates
$26
2024-12-19
Reason
Lake Street
Brooks O'Neil
Price Target
$26
2024-12-19
Initiates
Strong Buy
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for LifeVantage Corp (LFVN.O) is 12.16, compared to its 5-year average forward P/E of 8.10. For a more detailed relative valuation and DCF analysis to assess LifeVantage Corp 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Fair
5Y Average PE
8.10
Current PE
12.16
Overvalued PE
13.73
Undervalued PE
2.46
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
Fair
5Y Average EV/EBITDA
3.63
Current EV/EBITDA
5.60
Overvalued EV/EBITDA
6.30
Undervalued EV/EBITDA
0.95
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Overvalued
5Y Average PS
0.33
Current PS
0.61
Overvalued PS
0.59
Undervalued PS
0.07
Financials
Annual
Quarterly
FY2025Q3
YoY :
+21.13%
58.44M
Total Revenue
FY2025Q3
YoY :
+109.57%
4.05M
Operating Profit
FY2025Q3
YoY :
+109.16%
3.47M
Net Income after Tax
FY2025Q3
YoY :
+100.00%
0.26
EPS - Diluted
FY2025Q3
YoY :
-32.30%
1.90M
Free Cash Flow
FY2025Q3
YoY :
+2.61%
80.98
Gross Profit Margin - %
FY2025Q3
YoY :
+1.70%
5.39
FCF Margin - %
FY2025Q3
YoY :
+72.67%
5.94
Net Margin - %
FY2025Q3
YoY :
+151.97%
30.11
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
364.6K
USD
3
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
1
3.6K
USD
Months
6-9
3
15.5K
USD
Months
0-12
1
3.6K
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
364.6K
USD
3
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
1
3.6K
USD
Months
6-9
3
15.5K
USD
Months
0-12
1
3.6K
USD
Months
LFVN News & Events
Events Timeline
2025-03-17 (ET)
2025-03-17
08:08:23
LifeVantage expands global reach with international launch of MB System
2025-01-16 (ET)
2025-01-16
07:07:01
LifeVantage appoints Thompson as Chief Information, Innovation Officer
2025-01-13 (ET)
2025-01-13
07:27:42
LifeVantage announces results of third-party cell study of health weight stack
Sign Up For More Events
Sign Up For More Events
News
8.0
05-06NewsfilterLifeVantage Declares Quarterly Dividend
7.5
04-10BenzingaWhy ReShape Lifesciences Shares Are Trading Higher By Over 82%; Here Are 20 Stocks Moving Premarket
5.0
03-17NewsfilterLifeVantage Expands Global Reach with International Launch of the MB System™
Sign Up For More News
People Also Watch
MVIS
MicroVision Inc
1.100
USD
+2.80%
TSHA
Taysha Gene Therapies Inc
2.370
USD
+1.28%
TATT
TAT Technologies Ltd
33.490
USD
+0.06%
COFS
ChoiceOne Financial Services Inc
30.040
USD
-0.69%
PBPB
Potbelly Corp
10.180
USD
-1.26%
ORN
Orion Group Holdings Inc
8.650
USD
+2.13%
TTSH
Tile Shop Holdings Inc
6.030
USD
-3.67%
PDLB
Ponce Financial Group Inc
13.760
USD
-1.71%
XOMA
XOMA Corp
26.740
USD
-2.73%
GOCO
Gohealth Inc
7.500
USD
-7.52%
FAQ
What is LifeVantage Corp (LFVN) stock price today?
The current price of LFVN is 12.56 USD — it has increased 3.54 % in the last trading day.
What is LifeVantage Corp (LFVN)'s business?
What is the price predicton of LFVN Stock?
What is LifeVantage Corp (LFVN)'s revenue for the last quarter?
What is LifeVantage Corp (LFVN)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for LifeVantage Corp (LFVN)'s fundamentals?
How many employees does LifeVantage Corp (LFVN). have?